Physician profile
Jijun Xu
NPI 1831334218
$10,463.92
in general payments reported to CMS, 2019-2025
17 companies · $6,639 in 2025
The $6,639 reported for 2025 was more than what 94% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,103 · 2020: $534 · 2021: $346 · 2022: $422 · 2023: $308 · 2024: $1,113 · 2025: $6,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,155 · Travel and Lodging: $2,131 · Food and Beverage: $1,773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,155.00 |
| Travel and Lodging | $2,131.19 |
| Food and Beverage | $1,772.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $5,717.94 | 2025 | |
| Abbott Laboratories | $797.92 | 2019-2024 | Proclaim |
| Genentech, INC. | $755.00 | 2024 | |
| Nevro Corp. | $493.16 | 2019-2024 | Senza |
| Globus Medical, INC. | $486.06 | 2025 | Senza |
| Saluda Medical Americas, INC. | $483.30 | 2022-2025 | Evoke |
| Medtronic USA, INC. | $294.99 | 2019-2020 | |
| Averitas Pharma INC. | $294.31 | 2023 | Qutenza |
| Mml US, INC. | $238.74 | 2021 | |
| Boston Scientific Corporation | $232.27 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $125.02 | 2019-2023 | Cios Flow |
| Relievant Medsystems, INC. | $107.74 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $101.67 | 2019 | |
| Vertos Medical, INC. | $100.74 | 2024 | Mild Device Kit |
| Spr Therapeutics, INC | $95.85 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tonix Medicines, INC. | $77.10 | 2025 | |
| Grt US Holding, INC. | $62.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jijun Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.